相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT
Arnon Nagler et al.
BONE MARROW TRANSPLANTATION (2021)
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemia
Naranie Shanmuganathan et al.
BLOOD (2021)
Acute myeloid leukemia: current progress and future directions
Hagop Kantarjian et al.
BLOOD CANCER JOURNAL (2021)
Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality
Andrew J. Innes et al.
LEUKEMIA (2020)
Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study
Sijian Yu et al.
LEUKEMIA (2020)
Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT
Giorgia Battipaglia et al.
BONE MARROW TRANSPLANTATION (2019)
Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemia
Jonathan Canaani et al.
LEUKEMIA (2019)
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
Simona Piemontese et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis
Roni Shouval et al.
LANCET HAEMATOLOGY (2019)
Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease
Luca Maurillo et al.
CANCERS (2019)
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Jonathan Canaani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study
Andreas K. Ovlisen et al.
BLOOD ADVANCES (2018)
Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation
Jonathan Canaani et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2017)
Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission
A. Ruggeri et al.
BONE MARROW TRANSPLANTATION (2016)
An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation
Paul Ferguson et al.
HAEMATOLOGICA (2016)
Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first course
M. Othus et al.
LEUKEMIA (2016)
An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation
Paul Ferguson et al.
HAEMATOLOGICA (2016)
Inferior outcome after allogeneic transplant in first remission in high-risk AML patients who required more than two cycles of induction therapy
Sara J. Lim et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Shannon R. McCurdy et al.
BLOOD (2015)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea et al.
BLOOD (2015)
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L. Kasamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Number of Courses of Induction Therapy Independently Predicts Outcome after Allogeneic Transplantation for Acute Myeloid Leukemia in First Morphological Remission
Roland B. Walter et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Management of persistent AML at day 14
Elihu Estey
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2014)
Impact of Pretransplantation Risk Factors on Post Transplantation Outcome of Patients with Acute Myeloid Leukemia in Remission after Haploidentical Hematopoietic Stem Cell Transplantation
Yu Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Remission induction in acute myeloid leukemia
Eytan M. Stein et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Jan J. Cornelissen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Adult Patients With Acute Myeloid Leukemia Who Achieve Complete Remission After 1 or 2 Cycles of Induction Have a Similar Prognosis A Report on 1980 Patients Registered to 6 Studies Conducted by the Eastern Cooperative Oncology Group
Jacob M. Rowe et al.
CANCER (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
分享论文
